v3.25.2
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)
6 Months Ended 12 Months Ended
Aug. 12, 2024
Jul. 05, 2023
Mar. 31, 2025
Sep. 30, 2024
Sep. 30, 2023
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies [Line Items]          
Total shares outstanding (in Shares) 71,552,402        
Net amount $ 2,753,795   $ 2,753,795    
Additional paid in capital     89,308,821 $ 85,411,771 $ 43,658,750
Liabilities $ 559,015   559,015    
Transaction costs     2,358,780 2,358,780  
Cash contributions       3,827,944
Capital receivables       33,180,961  
Additional payable       $ 3,800,111
Stock split   675,000-for-1      
Citius Pharma [Member]          
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies [Line Items]          
Ownership percentage 92.30%        
TenX [Member]          
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies [Line Items]          
Additional paid in capital $ 395,015   395,015    
Cash $ 163,500   163,500    
Stock Split [Member]          
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies [Line Items]          
Stock split       675,000-for-1  
Citius Pharma [Member]          
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies [Line Items]          
Cash       $ 112  
Cash contributions     3,827,944    
Capital receivables     33,180,961    
Additional payable     $ 3,800,111